Cortazzo V, Pereyra Boza M, Tuccio Guarna Assanti V, Foglietta G, Vrenna G, Agosta M
Antibiotics (Basel). 2025; 14(2).
PMID: 40001393
PMC: 11851728.
DOI: 10.3390/antibiotics14020149.
Sandherr M, Stemler J, Schalk E, Hattenhauer T, Hentrich M, Hertenstein B
Lancet Reg Health Eur. 2025; 51:101214.
PMID: 39973942
PMC: 11836497.
DOI: 10.1016/j.lanepe.2025.101214.
Hall A, Hendricks H, Bowers K, Geller J, Bondoc A, Tiao G
Pediatr Transplant. 2025; 29(1):e70035.
PMID: 39868651
PMC: 11771635.
DOI: 10.1111/petr.70035.
Garcia-Garcia P, Palomo-Colli M, Silva-Jivaja K, Juarez-Villegas L, Vidal-Romero G, Sanchez-Rodriguez M
Mol Clin Oncol. 2025; 22(2):22.
PMID: 39776942
PMC: 11706457.
DOI: 10.3892/mco.2024.2817.
Li K, Guo B, Gu J, Ta N, Gu J, Yu H
Mater Today Bio. 2025; 30:101375.
PMID: 39759851
PMC: 11699619.
DOI: 10.1016/j.mtbio.2024.101375.
Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH.
Nucci M, Arrais-Rodrigues C, Bergamasco M, Garnica M, Gloria A, Guarana M
Hematol Transfus Cell Ther. 2024; 46 Suppl 6:S346-S361.
PMID: 39694764
PMC: 11726106.
DOI: 10.1016/j.htct.2024.11.119.
Myeloprotection effects of trilaciclib in Chinese patients with extensive stage small cell lung cancer (ES-SCLC) receiving chemotherapy-a real-world study.
Chen Y, Meng C, Liu L, Liu K, Chen T, Yang C
J Thorac Dis. 2024; 16(11):7233-7243.
PMID: 39678847
PMC: 11635219.
DOI: 10.21037/jtd-24-893.
Use of Granulocyte Transfusions in the Management of Severe Infections Among Children with Neutropenia.
Mielecka-Jarmocik G, Szymbor K, Balwierz W, Skoczen S, Len M, Kania K
J Pers Med. 2024; 14(11).
PMID: 39590599
PMC: 11595466.
DOI: 10.3390/jpm14111107.
Global landscape of vancomycin-resistant enterococci in hematopoietic stem-cell transplantation patients: a systematic review and meta-analysis.
Nabavi S, Chamanara M, Moghaddam A, Ghorbani M, Heidari R, Khomartash M
BMC Infect Dis. 2024; 24(1):1191.
PMID: 39438823
PMC: 11515653.
DOI: 10.1186/s12879-024-10100-0.
A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer.
Zhang Q, Wang Z, Yao W, Wang S, Zhang G, Chen J
BMC Cancer. 2024; 24(1):1143.
PMID: 39272058
PMC: 11395217.
DOI: 10.1186/s12885-024-12892-5.
Genetic susceptibility to breast cancer increases the risk of neutropenia and agranulocytosis: insights from Mendelian randomization.
Wei C, Zhang G, Li C, Zeng J
Support Care Cancer. 2024; 32(7):472.
PMID: 38949722
DOI: 10.1007/s00520-024-08682-1.
The Burden of Invasive Fungal Disease Following Chimeric Antigen Receptor T-Cell Therapy and Strategies for Prevention.
Little J, Kampouri E, Friedman D, McCarty T, Thompson 3rd G, Kontoyiannis D
Open Forum Infect Dis. 2024; 11(6):ofae133.
PMID: 38887472
PMC: 11181190.
DOI: 10.1093/ofid/ofae133.
Immunosuppression at ICU admission is not associated with a higher incidence of ICU-acquired bacterial bloodstream infections: the COCONUT study.
Zebian G, Kreitmann L, Houard M, Piantoni A, Piga G, Ruffier des Aimes S
Ann Intensive Care. 2024; 14(1):83.
PMID: 38837065
PMC: 11153408.
DOI: 10.1186/s13613-024-01314-1.
Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data.
Badawy S, Palmblad J, Tricta F, Temin N, Fradette C, Lin L
Blood Adv. 2024; 8(21):5641-5649.
PMID: 38640437
PMC: 11565021.
DOI: 10.1182/bloodadvances.2023012316.
Granulocyte Transfusions in Neutropenic Infections: Insights From a Single-Center Study.
Ozkan S, Kimiaei A, Safaei S, Sonmezoglu M, Ozkan H
Cureus. 2024; 16(3):e55953.
PMID: 38601410
PMC: 11005880.
DOI: 10.7759/cureus.55953.
"Moderate" adjuvant chemotherapy-induced leukopenia is beneficial for survival of patients with early breast cancer: a retrospective study.
Wang L, Jiang C, Wang N, Wen Y, Wang S, Xue C
BMC Cancer. 2023; 23(1):1227.
PMID: 38093246
PMC: 10720186.
DOI: 10.1186/s12885-023-11680-x.
Markers of intestinal mucositis to predict blood stream infections at the onset of fever during treatment for childhood acute leukemia.
Weischendorff S, Rathe M, Petersen M, Weimann A, Enevold C, Nielsen C
Leukemia. 2023; 38(1):14-20.
PMID: 37919603
PMC: 10776407.
DOI: 10.1038/s41375-023-02077-7.
Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy.
Bachlitzanaki M, Aletras G, Bachlitzanaki E, Messaritakis I, Koukias S, Koulouridi A
Microorganisms. 2023; 11(10).
PMID: 37894205
PMC: 10609470.
DOI: 10.3390/microorganisms11102547.
Effectiveness of levofloxacin in the induction of chemotherapy in high-risk acute lymphoblastic leukaemia in children in a developing country.
Ejaz A, Belgaumi A, Alam S, Ashraf M, Raza M
Ecancermedicalscience. 2023; 17:1606.
PMID: 37799940
PMC: 10550328.
DOI: 10.3332/ecancer.2023.1606.
AML consolidation therapy: timing matters.
Reimann A, Schalk E, Jost F, Mougiakakos D, Weber D, Dohner H
J Cancer Res Clin Oncol. 2023; 149(15):13811-13821.
PMID: 37535164
PMC: 10590325.
DOI: 10.1007/s00432-023-05115-0.
